Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    J Bodyw Mov Ther. 2010 Apr;14(2):162-71. doi: 10.1016/j.jbmt.2010.01.002. Epub 2010 Jan 29.

    In vitro modeling of repetitive motion injury and myofascial release.

    Source

    Department of Basic Medical Sciences, University of Arizona, College of Medicine, Phoenix, AZ 85004-2157, USA.

    Abstract

    OBJECTIVE:

    In this study we modeled repetitive motion strain (RMS) and myofascial release (MFR) in vitro to investigate possible cellular and molecular mechanisms to potentially explain the immediate clinical outcomes associated with RMS and MFR.

    METHOD:

    Cultured human fibroblasts were strained with 8h RMS, 60s MFR and combined treatment; RMS+MFR. Fibroblasts were immediately sampled upon cessation of strain and evaluated for cell morphology, cytokine secretions, proliferation, apoptosis, and potential changes to intracellular signaling molecules.

    RESULTS:

    RMS-induced fibroblast elongation of lameopodia, cellular decentralization, reduction of cell to cell contact and significant decreases in cell area to perimeter ratios compared to all other experimental groups (p<0.0001). Cellular proliferation indicated no change among any treatment group; however RMS resulted in a significant increase in apoptosis rate (p<0.05) along with increases in death-associated protein kinase (DAPK) and focal adhesion kinase (FAK) phosphorylation by 74% and 58% respectively, when compared to control. These responses were not observed in the MFR and RMS+MFR group. Of the 20 cytokines measured there was a significant increase in GRO secretion in the RMS+MFR group when compared to control and MFR alone.

    CONCLUSION:

    Our modeled injury (RMS) appropriately displayed enhanced apoptosis activity and loss of intercellular integrity that is consistent with pro-apoptotic dapk-2 and FAK signaling. Treatment with MFR following RMS resulted in normalization in apoptotic rate and cell morphology both consistent with changes observed in dapk-2. These in vitro studies build upon the cellular evidence base needed to fully explain clinical efficacy of manual manipulative therapies.

    Copyright 2010 Elsevier Ltd. All rights reserved.

    PMID:
    20226363
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2853774
    Free PMC Article

    Images from this publication.See all images (7)Free text

    Figures 1
    Figure 2
    Figure 3
    Figure 4
    Figure 5
    Figure 6
    Figure 7

      Supplemental Content

      Icon for Elsevier Science Icon for PubMed Central

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk